A Long-term Safety Study of Once-daily Travatan

NCT00051168 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

502

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma, Open-angle
Ocular Hypertension

Interventions

DRUG: Travatan

Sponsor

Alcon Research